Masters of Health Magazine December 2021 | Page 14

Since 1999, at least 4,000 patents involving coronavirus have been filed, including patents detailing key features of the so-called “novel” SARS-CoV-2 virus. In 2002, Ralph Baric, Ph.D. and colleagues at the University of North Carolina, Chapel Hill, filed a patent on recombinant coronavirus, and within a year, we got the world’s first SARS outbreak.

In this interview, Dr. Mercola continue his coverage of the COVID “plandemic” by speaking to David Martin, Ph.D., who has done a phenomenal job uncovering the paper trail behind the virus now known as SARS-CoV-2.

As it turns out, this is not a novel virus at all, as patents and government grants detailing key features of the virus go back two decades. Martin finished his doctorate at the University of Virginia in 1995, after which he was hired on to the medical school faculty in radiology and orthopedic surgery.

In 2006, he set up the first medical device clinical trials organization for the University of Virginia — a company called IDEAmed — which conducted medical device clinical trials for U.S. Food and Drug Administration (FDA) submission. So, he has an extensive background working with FDA clinical trials.

Story at-a-glance:

In the early 2000s, David Martin, Ph.D., founder of M-CAM International, started finding large numbers of patents that violate biological and chemical weapons laws.

In 1999, Dr. Anthony Fauci funded research to create “an infectious replication-defective recombinant coronavirus.” In 2002, Ralph Baric, Ph.D. and colleagues at the University of North Carolina, Chapel Hill, filed a patent on recombinant coronavirus, and within a year, we got the world’s first SARS outbreak.

Since 1999, at least 4,000 patents involving coronavirus have been filed, including patents detailing key features of the so-called “novel” SARS-CoV-2 virus.

The 2001 anthrax attack, which came out of medical and defense research, led to the passage of the PREP Act, which removed liability for manufacturers of emergency medical countermeasures.

The funds for entitlement programs and pensions will dry up by 2028, at which point the drug industry will go bankrupt as well. With a burgeoning population that is sick from the COVID jabs, we need to prepare new systems to care for each other.

4,000 Patents: Why the ‘Novel’ SARS-CoV-2 Virus Isn’t so Novel

Interview by Dr. Joseph Mercola